Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4 (3 methylphenoxy)benzonitrile. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120535435A reveals a safer two-phase synthesis for crisaborole intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.